The investigation commenced by evaluating NAT10 expression using IHC on an NSCLC tissue microarray (TMA) comprising 180 samples from 98 NSCLC patients, alongside adjacent normal tissues (Table S1). This evidence concerns the gene NAT10 and non-small cell lung carcinoma.